Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL26099219

COc1cc2c(-c3ccc(N)cc3)ncnc2cc1OCC1CCN(C)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.57
▸ KDR P35968 5/20 0.52
▸ KIT P10721 4/20 0.51
▸ FGFR1 P11362 3/20 0.50
▸ FLT1 P17948 3/20 0.50
▸ FLT4 P35916 3/20 0.50
▸ RET P07949 2/20 0.50
▸ KIF5B P33176 2/20 0.50
▸ PDGFRB P09619 2/20 0.50
▸ TEK Q02763 2/20 0.50
▸ BMPR1B O00238 1/20 0.50
▸ PLK4 O00444 1/20 0.50
▸ CIT O14578 1/20 0.50
▸ GAK O14976 1/20 0.50
▸ EPHB6 O15197 1/20 0.50
▸ RIPK2 O43353 1/20 0.50
▸ ROCK2 O75116 1/20 0.50
▸ STK10 O94804 1/20 0.50
▸ MAP4K4 O95819 1/20 0.50
▸ ABL1 P00519 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30393893 0.91 EGFR (0.64) EGFRKDRKITFGFR1FLT1
SCHEMBL26100098 0.84 EGFR (0.56) EGFRKDRKITFGFR1FLT1
SCHEMBL26101933 0.83 EGFR (0.49) EGFRKDRKITFGFR1FLT1
SCHEMBL30394062 0.83 EGFR (0.49) EGFRKDRKITFGFR1FLT1
SCHEMBL26100102 0.82 EGFR (0.62) EGFRKDRKIT
SCHEMBL26102560 0.80 EGFR (0.48) EGFRKDRKITFGFR1FLT1
SCHEMBL26100068 0.80 EGFR (0.57) EGFRKDRKITFGFR1FLT1
SCHEMBL30394491 0.80 EGFR (0.57) EGFRKDRKITFGFR1FLT1
SCHEMBL30394389 0.79 KDR (0.53) EGFRKDRKIT
SCHEMBL29238264 0.79 KDR (0.53) EGFRKDRKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023075529-A1 QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF 보로노이바이오 주식회사 2023-05-04 — — WO disclosed
Send feedback